{"id":859396,"date":"2025-06-11T07:04:43","date_gmt":"2025-06-11T11:04:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/"},"modified":"2025-06-11T07:04:43","modified_gmt":"2025-06-11T11:04:43","slug":"castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/","title":{"rendered":"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">FRIENDSWOOD, Texas, June  11, 2025  (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during the 2025 BIO International Convention (BIO 2025), being held June 16-19 in Boston. The panel will explore the challenges precision medicine companies face in commercializing innovative diagnostic tests and discuss strategies for navigating today&#8217;s market complexities while remaining focused on improving care for patients.<\/p>\n<p>\n        <strong>Panel Details:<\/strong><br \/>\n        <br \/>\n        <strong>Title:<\/strong> Advancing Innovative Risk-Stratification Tests That Impact Treatment Pathway Decisions: Challenges in Overcoming Barriers to Entry<br \/><strong>Date &amp; Time:<\/strong> Tuesday, June 17, 2025, from 11 a.m.-12 p.m. Eastern Time<br \/><strong>Location: <\/strong>Room 251<br \/><strong>Focus Area: <\/strong>Diagnostics and Personalized Medicine<br \/><strong>Session Type<\/strong>: Breakout Session<\/p>\n<p>\n        <strong>Moderator:<\/strong> Michael Ryan, J.D., Partner, McDermott Will &amp; Emery<br \/><strong>Panel Participants:<\/strong><\/p>\n<ul type=\"disc\">\n<li>Mara Aspinall, Partner, Illumina Ventures<\/li>\n<li>Gillian Hooker, Ph.D., ScM, CGC, Chief Scientific Officer, Concert<\/li>\n<li>Derek Maetzold, Founder, President and CEO, Castle Biosciences<\/li>\n<\/ul>\n<p>Castle is also a member of the City of Phoenix and Texas delegations attending BIO 2025. For information on Castle, please visit the City of Phoenix Pavilion (1639) or the Texas Pavilion (2665).<\/p>\n<p>To register to attend BIO 2025, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9j8Bs7m23pB6yqJutQlc0IXtJROmVeEI0RoPyg-ovRvQLgdY3kf9eQ7wE_WscLFdx5BkEBoC4LIZUdah6ihaNnHrKQzjyMyfq-TScc9NweU=\" rel=\"nofollow\" target=\"_blank\">convention.bio.org<\/a>.<\/p>\n<p>\n        <strong>About BIO<\/strong>\u202f\u00a0<br \/>BIO is the world&#8217;s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eC4K_EY9CB4hQYGnjw4MInUVg7QyPuvbLu8Dq6dC_eeWQWE_4e2Cpsj0SF3TQFyDDGnOXSoxd6JNmf-OIEiCLx49-z99mNIjQEp5lQfcT85fjTtN2f4hw1Xa-wJU9Wyq\" rel=\"nofollow\" target=\"_blank\">BIO International Convention<\/a>, the world&#8217;s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.\u202f\u00a0<\/p>\n<p>\n        <strong>About Castle Biosciences<\/strong><br \/>\n        <br \/>Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.<\/p>\n<p>Castle\u2019s current portfolio consists of tests for skin cancers, Barrett\u2019s esophagus and uveal melanoma.\u00a0Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=STlvc02vUy0XADasNJweatvv0eGwRACAhP9z_HonVFc4tlNZvDSLJeE9Ol9zp7pg4J_lUSihDOYlJfKgr2_wn9AkoACg4CEmNZf-XdOkgwrRSaZbLUZ4M3j5HTFzA_iU\" rel=\"nofollow\" target=\"_blank\">www.CastleBiosciences.com<\/a> and connect with us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wNS1NeLAjVQ5IdLHUdk_c9boGgik9IN4d1Yt2lf4fI-wwpR_A5vE4f5V4JNsYI8nbuzJx_HlCF_3eHBOATAVUarAhNdiW0hEg2oSkIO8s2ShvbYSEgnin7GRWW7lqyJU\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oEyEL5XXaxjA46BYJbZa514sft7WY4A6WeEfRnCWf9oruy8aNR0aW6PyGr0mzIs1SMALtB8teX8LPcT2lBdfG7mO9ShABVU83eHwA6fpazE=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vlIywg_6-gITp8C7szi35X7xCmfyRI65vNuWnpULyuFuCZlggtLWPpqD884EGHvVDnxJomAcUVRHqJiUCmY6g7yUkbBfALKTwvaaAhVILIc=\" rel=\"nofollow\" target=\"_blank\">X<\/a> and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0g3ZipO93A9B9eqwnMFM9mO5BvtuD_NxupfG_MwUvPAJzqD-cYoiWchWHwMf130VgE8NVaQqpb08tVeIIhBWuc7CUyXxi1ZdR31zVRwEVU8=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.\u202f<\/p>\n<p>DecisionDx-Melanoma, DecisionDx-CM<em>Seq<\/em>, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UM<em>Seq<\/em> are trademarks of Castle Biosciences, Inc.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Camilla Zuckero<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qDp4ih8gr4N_wM6zUDu67Cl_u2EKcodBfh9AtBhN74toDVHE3MExtuL6qyBkar_NrCpp4TQJUzfF1G6jeZqNmA5HQYN4CdBNI19CHQsZ1xkXrEw-_YgUKconWtXYfpd6\" rel=\"nofollow\" target=\"_blank\">czuckero@castlebiosciences.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Allison Marshall<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vq-Qi8UbeHpOtwNKjB7ue_caDWENR5wMYlOw44pV_SLFgbvKbFWhFB_0KqZ1Fd_cLk2DmjIj2_rboy3VVuNSuqgWNVvXqv_jICjmuALa6CRQ7skd4Y7v9MkQTZYlmMll2nsNGtd40EGHx5y-n_-zXg==\" rel=\"nofollow\" target=\"_blank\">amarshall@castlebiosciences.com<\/a><\/p>\n<p>\n        <strong>Source: <\/strong>Castle Biosciences Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWVjNDhlNTUtMjRhZC00NDJlLThlYmQtOGQ5NzJjOTRlMDdlLTExMDc2NDUtMjAyNS0wNi0xMS1lbg==\/tiny\/Castle-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during the 2025 BIO International Convention (BIO 2025), being held June 16-19 in Boston. The panel will explore the challenges precision medicine companies face in commercializing innovative diagnostic tests and discuss strategies for navigating today&#8217;s market complexities while remaining focused on improving care for patients. Panel Details: Title: Advancing Innovative Risk-Stratification Tests That Impact Treatment Pathway Decisions: Challenges in Overcoming Barriers to EntryDate &amp; Time: Tuesday, June 17, 2025, from 11 a.m.-12 p.m. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-859396","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during the 2025 BIO International Convention (BIO 2025), being held June 16-19 in Boston. The panel will explore the challenges precision medicine companies face in commercializing innovative diagnostic tests and discuss strategies for navigating today&#8217;s market complexities while remaining focused on improving care for patients. Panel Details: Title: Advancing Innovative Risk-Stratification Tests That Impact Treatment Pathway Decisions: Challenges in Overcoming Barriers to EntryDate &amp; Time: Tuesday, June 17, 2025, from 11 a.m.-12 p.m. &hellip; Continue reading &quot;Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-11T11:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention\",\"datePublished\":\"2025-06-11T11:04:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/\"},\"wordCount\":446,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/\",\"name\":\"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=\",\"datePublished\":\"2025-06-11T11:04:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/","og_locale":"en_US","og_type":"article","og_title":"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Market Newsdesk","og_description":"FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during the 2025 BIO International Convention (BIO 2025), being held June 16-19 in Boston. The panel will explore the challenges precision medicine companies face in commercializing innovative diagnostic tests and discuss strategies for navigating today&#8217;s market complexities while remaining focused on improving care for patients. Panel Details: Title: Advancing Innovative Risk-Stratification Tests That Impact Treatment Pathway Decisions: Challenges in Overcoming Barriers to EntryDate &amp; Time: Tuesday, June 17, 2025, from 11 a.m.-12 p.m. &hellip; Continue reading \"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-11T11:04:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention","datePublished":"2025-06-11T11:04:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/"},"wordCount":446,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/","name":"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=","datePublished":"2025-06-11T11:04:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjU5MiM2OTg1MDI3IzIwOTYwNzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Castle Biosciences\u2019 Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=859396"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=859396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=859396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=859396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}